Skip to main content
. 2020 Jan 17;8(3):e1129. doi: 10.1002/mgg3.1129

Table 1.

Clinical manifestations in patients with DDCH due to isolated BCAP31 mutation and due to Xq28 microdeletion

Characteristics Isolated BCAP31 mutation Xq28 microdeletion

Family 1

Cacciagli et al.

Family2

Cacciagli et al.

Family3

Cacciagli et al.

Albanyan et al. Current Patient

Osaka et al.

Anselm et al.

Corzo et al.

Kamp et al.

Iwasa et al.

Corzo et al.

Kamp et al.

Calhoun et al.

Genotype c.194−2A > G Exon 8 deletion c.97C > T c.533_536dup c.97C > T BCAP31 and SLC6A8 deletion BCAP31and ABCD1 deletion

BCAP31, SLC6A8

and ABCD1 deletion

Patient number n = 2 n = 4 n = 1 n = 1 n = 1 n = 2 n = 4 n = 3

Age or

Age at death

death

at 13 and 24 years

death at

7 months−2 years

except one living at 13 years

death at 3 years

living at

4.5 years

living at

8 years 8 months

one living at 9 years the other death at

8 years,

all death at 4–11 months All death at 4–9 months

Developmental

and cognitive status

no acquired motor milestones no cognitive sign

no acquired‐only head control

except one sitting at 5 years

only head control

no cognitive sign

no acquired motor milestones

no cognitive sign

only head control

and roll over,

no speech

no acquired

motor milestones

severe delay

no acquired

motor

milestones

Deafness + + (n = 3) + + + + + (n = 3) + (n = 1)
Dystonia or Choreoathetosis + + (n = 3) + + + + + +
Brain MRI

hypomyelination

cerebral and cerebellar atrophy

hypomyelination

hypomyelination

cerebral atrophy

high SI in globus pallidus

high SI in thalamus and globus pallidus

cerebral atrophy

hypomyelination,

high SI in basal

ganglia or globus pallidus,

cerebral and

cerebellar atrophy

hypomyelination,

white matter abnormalities

hypomyelination

Hepatobiliary

abnormality

NMa NMa NMa elevated transaminase cholecystitis with gallbladder stones

Elevated

transaminase

cholestasis

fibrosis

liver failure

cholestasis

liver failure

Mitochondrial respiratory chain activity NM NM normal normal significant decrease in complex I significant decrease in complex I (n = 1) NM NM
Other mitochondrial abnormality pleomorphic subsarcolemmal mitochondria NE NM NM NM

+, the feature present; −, the feature absent; SI, signal intensities; NM, the feature not mentioned; NE, the feature not evaluated.

a

The feature was not mentioned according to each family, but four patients among all the families reported by Cacciagli displayed mild elevated transaminase.